Subclinical hypothyroidism is defined biochemically as an elevated serum thyroid-stimulating hormone (TSH) concentration in the presence of normal circulating free thyroxine (Free T4) and free triiodothyronine (Free T3) levels. Evaluating the clinical indications for levothyroxine initiation requires assessing autoantibody status, cardiovascular risk factors, and symptomatic burden.
Thyroid Diagnostic Laboratory Reference Framework
| Assay | Standard Reference Range | Functional / Optimal Range | Clinical Significance |
|---|---|---|---|
| TSH (µIU/mL) | 0.45 – 4.50 µIU/mL | 1.0 – 2.0 µIU/mL | Pituitary feedback index; values > 10 µIU/mL warrant treatment |
| Free T4 (ng/dL) | 0.82 – 1.77 ng/dL | 1.1 – 1.4 ng/dL | Circulating prohormone available for peripheral deiodination |
| Free T3 (pg/mL) | 2.0 – 4.4 pg/mL | 3.0 – 3.8 pg/mL | Biologically active hormone binding nuclear thyroid receptors |
| Anti-TPO Antibodies (IU/mL) | < 9 IU/mL | < 2 IU/mL | Autoimmune marker for Hashimoto's Thyroiditis |